| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |